Mayo Clinic Opioid Conference: Evidence, Clinical Considerations, and Best Practice 2022

Our patient-centric approach to controlled substance monitoring is backed by more than 150 years of medical knowledge and developed by an award-winning team of pain medicine, primary care, and addiction experts who work collaboratively with the Clinical and Forensic Toxicology Laboratory at Mayo Clinic. Our tests are based on practice guidelines developed by the American Association for Clinical Chemistry Academy and provide clinicians with assistance to ensure patients who receive controlled substance therapy remain within regulatory parameters.

Learn from Loralie J. Langman, Ph.D.

Friday, September 30, 2022, 11:05 a.m. PST

Learning objectives

• Integrate urine drug testing to support the treatment and monitoring of pain management patients.

• Describe the limitations of various screening and quantitative urine drug tests. 

• Interpret urine drug testing results from pain management patients.


Learn more about

Therapeutics testing

Controlled substance monitoring

Targeted testing for opioid use

Digital resources

AACC Laboratory Medicine Practice Guidelines  

New High-Resolution Targeted Opioid Screen

Laboratory Detection of Opioids

Printable documents

Pain Management Testing Services Overview

Controlled Substance Monitoring Brochure

Targeted Opioid Monitoring Flyer

Opioids Pharmacokinetics Chart

Therapeutics Request Form

Contact us